Skip to main content
. 2019 Apr 26;26(2):176–185. doi: 10.5603/CJ.a2018.0020

Table 2.

The risk of negative clinical outcomes for patients with low and high high-density lipoprotein cholesterol (HDL-C) level in the propensity-adjusted cohort.

Low HDL-C High HDL-C


HR (95% CI) P HR (95% CI) P
Cardiovascular death and MI 1.755 (1.274–2.417) 0.001 0.562 (0.275–1.146) 0.113
Cardiovascular death 2.233 (1.465–3.404) < 0.001 0.775 (0.359–1.675) 0.517
Recurrent MI 1.203 (0.725–1.996) 0.474 0.192 (0.027–1.389) 0.102
All-cause death 1.486 (1.084–2.036) 0.014 0.964 (0.556–1.673) 0.897
MACE 1.022 (0.877–1.190) 0.65 0.915 (0.697–1.202) 0.524

CI — confidence interval; HR — hazard ratio; MI — myocardial infarction; MACE — major adverse cardiac event